The Kidney Health Initiative's (KHI) mission is to advance scientific understanding of the kidney health and patient safety implications of new and existing medical products while fostering the development of therapies for diseases that affect the kidney by creating a collaborative environment in which US Food and Drug Administration (FDA) and the greater nephrology community can interact to optimize evaluation of drugs, devices, biologics, and food products.
… As medicine evolves into the provision of personalized care, so too must care for patients or people living with kidney diseases. KHI, through its multidisciplinary partners, is poised to meet these challenges and ensure the safe introduction of new technologies and therapeutics to enhance the care of patients with kidney diseases.
Mark Okusa, MD, FASN
2018 President of the American Society of Nephrology